1529145315340722178

Recent HEOR study projects that omidubicel, if approved, may offer allo-transplanters a new standard of care and curative approach. Learn more here: https://t.co/fEUfvVbnQn

#healthequity https://t.co/SQWCpBb31g

Send us a message